<DOC>
	<DOCNO>NCT02595008</DOCNO>
	<brief_summary>study evaluate potential DSXS suppress HPA axis function patient moderate severe atopic dermatitis .</brief_summary>
	<brief_title>Study Assess Potential Adrenal Suppression Following Treatment With DSXS Patients With Atopic Dermatitis</brief_title>
	<detailed_description>The objective study evaluate potential DSXS suppress HPA axis function patient moderate severe atopic dermatitis . The secondary objective evaluate evaluate adverse event ( AE ) profile DSXS administer patient moderate severe atopic dermatitis .</detailed_description>
	<mesh_term>Dermatitis</mesh_term>
	<mesh_term>Dermatitis , Atopic</mesh_term>
	<mesh_term>Eczema</mesh_term>
	<criteria>Patients definite clinical diagnosis stable atopic dermatitis Patient age 2</criteria>
	<gender>All</gender>
	<minimum_age>2 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>